| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |